loader image

Eos portfolio business ClinSpec DX secures a further £2.4m in Funding for Early Cancer Detection Tech

The Glasgow-based company is hoping to use the funding to support further development of testing technology. ClinSpec Diagnostics Limited (ClinSpec Dx) has secured £2.4 million in investment from an Eos lead syndicate to help develop a new technology that can detect cancer at an early stage using blood tests. The ClinSpec Dx blood test uses … Read more

Latest news

SEIS limit increased to £250k
03 October 2022
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
06 September 2022

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.